Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease

Figure 1

Results of serum Hb, MMP-9, and NT-proBNP concentrations in CKD patients and control group. Hb = hemoglobin, MMP-9 = metalloproteinase-9, NT-proBNP = N-terminal pro-brain natriuretic peptide, and CKD = chronic kidney disease.